Ambalal Sarabhai’s JV receives CDSCO license to manufacture CHIKV Test Kit

23 Mar 2021 Evaluate

CoSara Diagnostics, a Joint Venture (JV) of a subsidiary of Ambalal Sarabhai Enterprises and Co-Diagnostics, Inc, Salt Lake City, Utah, USA,  has obtained regulatory approval from Central Drugs Standard Control Organisation (CDSCO) to manufacture and sale SARAGENE Chikungunya Virus (CHIKV) Test Kit for diagnosis of Chikungunya Virus.

The Test Kit is an in vitro diagnostic test, based on Real-Time Polymerase Chain Reaction Technology. Test utilizes Co-Diagnostics' patented CoPrimers technology (Satterfield, 2014) (Poritz & Ririe, 2014). It tests for the presence or absence of ribonucleic acid (RNA) of chikungunya virus in serum or plasma from patients suspected of chikungunya viral infections.

Ambalal Sarabhai Enterprises is engaged in manufacturing and marketing of pharmaceutical products, bulk drugs, industrial chemicals, detergents, toiletries, electronics, engineering products, paper, glass and plastic containers and packaging materials.

Ambalal Sarabhai Ent Share Price

38.00 1.28 (3.49%)
11-Apr-2025 14:21 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1686.50
Dr. Reddys Lab 1119.05
Cipla 1459.50
Lupin 1972.00
Zydus Lifesciences 867.75
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...